← Back to Search

Active Group for COVID-19

N/A
Waitlist Available
Research Sponsored by Western University, Canada
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measurements will be made prior to commencement of exercise protocols.
Awards & highlights

Study Summary

This trial will help researchers understand if exercise can help protect the cardiovascular system by keeping levels of ACE2 and ACE balanced.

Eligible Conditions
  • COVID-19

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measurements will be taken before, immediately post and 30 minutes post exercise.
This trial's timeline: 3 weeks for screening, Varies for treatment, and measurements will be taken before, immediately post and 30 minutes post exercise. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in the mean response to an acute bout of physical activity in the components of the renin-angiotensin system
Secondary outcome measures
Changes in the baseline measurements of the renin-angiotensin system between physically active and sedentary males.

Trial Design

2Treatment groups
Active Control
Group I: Active GroupActive Control1 Intervention
Individuals who are physically active for greater than 150 minutes of moderate to vigorous physical activity will be placed in the active group.
Group II: Sedentary GroupActive Control1 Intervention
Individuals who are physically active for less than 75 minutes of moderate to vigorous physical activity a week will be placed in the sedentary group.

Find a Location

Who is running the clinical trial?

Western University, CanadaLead Sponsor
239 Previous Clinical Trials
57,429 Total Patients Enrolled
2 Trials studying COVID-19
200 Patients Enrolled for COVID-19

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are investigators currently welcoming new participants into this research?

"The data available on clinicaltrials.gov specifies that this trial is not currently seeking participants, even though it was first published on July 8th 2022 and recently updated 12 days ago. Nevertheless, there are still 180 other medical studies which require candidates to join their trials."

Answered by AI

What are the eligibility requirements for participation in this research initiative?

"To qualify for acceptance into this medical trial, a patient must suffer from acute lung injury and be between 18-39 years old. 24 participants will ultimately join the study."

Answered by AI

Is eligibility for the experiment open to geriatric patients?

"The age brackets for eligibility in this research are 18 to 39 years old. Separately, there are 53 clinical trials designed exclusively for minors and 131 specifically tailored towards the elderly population."

Answered by AI
~9 spots leftby Apr 2025